ArticleFrontiers in oncology2023

Combined NK-CIK and PD-1 inhibitor (nivolumab), an effective immunotherapy for treating intrahepatic lymphoepithelioma-like cholangiocarcinoma unassociated with EBV infection: Two case reports and a literature review.

Alen Sam Saji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.